Paper8367455
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J and 9 others. Proc Natl Acad Sci U S A, 1993. Cited by 116 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Papers, record 8367455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8367455
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| Bacterial Proteins | Major topic |
| Escherichia coli Proteins | Major topic |
| Gene Products, tat | Major topic |
| Genetic Therapy | Major topic |
| HIV-1 | Major topic |
| Membrane Proteins | Major topic |
| RNA, Catalytic | Major topic |
| RNA, Viral | Major topic |
| Receptors, Cell Surface | Major topic |
| Simian Immunodeficiency Virus | Major topic |
| Virus Replication | Major topic |
| Animals | |
| Cell Line | |
| Chemoreceptor Cells | |
| Genes, gag | |
| HIV Long Terminal Repeat | |
| Humans | |
| In Situ Hybridization | |
| Plasmids | |
| Restriction Mapping | |
| T-Lymphocytes | |
| Transfection | |
| tat Gene Products, Human Immunodeficiency Virus |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2831375 | A safe packaging line for gene transfer: separating viral genes on two different plasmids. | J Virol | 1988 | https://conductscience.org/library/papers/2831375 | PubMed |
| 2 | 2825351 | Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. | Science | 1987 | https://conductscience.org/library/papers/2825351 | PubMed |
| 3 | 2536828 | Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. | J Virol | 1989 | https://conductscience.org/library/papers/2536828 | PubMed |
| 4 | 2542934 | Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2542934 | PubMed |
| 5 | 2478293 | Tat trans-activates the human immunodeficiency virus through a nascent RNA target. | Cell | 1989 | https://conductscience.org/library/papers/2478293 | PubMed |
| 6 | 2184372 | Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. | Nature | 1990 | https://conductscience.org/library/papers/2184372 | PubMed |
| 7 | 2225067 | Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. | Cell | 1990 | https://conductscience.org/library/papers/2225067 | PubMed |
| 8 | 2227414 | A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. | Genes Dev | 1990 | https://conductscience.org/library/papers/2227414 | PubMed |
| 9 | 1848369 | An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. | Science | 1991 | https://conductscience.org/library/papers/1848369 | PubMed |
| 10 | 2562188 | The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. | New Biol | 1989 | https://conductscience.org/library/papers/2562188 | PubMed |
| 11 | 2039768 | Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. | New Biol | 1991 | https://conductscience.org/library/papers/2039768 | PubMed |
| 12 | 1646840 | Model for studying virus attachment. II. Binding of biotinylated human T cell leukemia virus type I to human blood mononuclear cells potential targets for human T cell leukemia virus type I infection. | J Immunol | 1991 | https://conductscience.org/library/papers/1646840 | PubMed |
| 13 | 1589762 | Human gene therapy. | Science | 1992 | https://conductscience.org/library/papers/1589762 | PubMed |
| 14 | 1608446 | Human gene therapy comes of age. | Nature | 1992 | https://conductscience.org/library/papers/1608446 | PubMed |
| 15 | 1321271 | Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas. | J Virol | 1992 | https://conductscience.org/library/papers/1321271 | PubMed |
| 16 | 1279199 | Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. | J Virol | 1992 | https://conductscience.org/library/papers/1279199 | PubMed |
| 17 | 8416373 | Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. | J Virol | 1993 | https://conductscience.org/library/papers/8416373 | PubMed |
| 18 | 2988790 | The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. | Cell | 1985 | https://conductscience.org/library/papers/2988790 | PubMed |
| 19 | 2990040 | Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Science | 1985 | https://conductscience.org/library/papers/2990040 | PubMed |
| 20 | 2435942 | Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone. | J Natl Cancer Inst | 1987 | https://conductscience.org/library/papers/2435942 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32288940 | Molecular recognition elements: DNA/RNA-aptamers to proteins. | Biochem Mosc Suppl B Biomed Chem | 2010 | https://conductscience.org/library/papers/32288940 | PubMed |
| 26079406 | Cell-based gene therapy against HIV. | Gene Ther | 2015 | https://conductscience.org/library/papers/26079406 | PubMed |
| 25636849 | Inducible suppression of global translation by overuse of rare codons. | Appl Environ Microbiol | 2015 | https://conductscience.org/library/papers/25636849 | PubMed |
| 23028130 | Novel cell and gene therapies for HIV. | Cold Spring Harb Perspect Med | 2012 | https://conductscience.org/library/papers/23028130 | PubMed |
| 20737298 | The use of cell-delivered gene therapy for the treatment of HIV/AIDS. | Immunol Res | 2010 | https://conductscience.org/library/papers/20737298 | PubMed |
| 17565699 | Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1. | Retrovirology | 2007 | https://conductscience.org/library/papers/17565699 | PubMed |
| 16109172 | CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. | Retrovirology | 2005 | https://conductscience.org/library/papers/16109172 | PubMed |
| 15813990 | HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. | AIDS Res Ther | 2005 | https://conductscience.org/library/papers/15813990 | PubMed |
| 15813986 | Lentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages. | AIDS Res Ther | 2004 | https://conductscience.org/library/papers/15813986 | PubMed |
| 12376617 | A nucleolar TAR decoy inhibitor of HIV-1 replication. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12376617 | PubMed |
| 11907228 | Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production. | J Virol | 2002 | https://conductscience.org/library/papers/11907228 | PubMed |
| 11438838 | SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters. | Gene Ther | 2001 | https://conductscience.org/library/papers/11438838 | PubMed |
| 11368355 | Gene therapy: principles and applications to hematopoietic cells. | Leukemia | 2001 | https://conductscience.org/library/papers/11368355 | PubMed |
| 11287684 | Gene therapy for HIV. | Sex Transm Infect | 2001 | https://conductscience.org/library/papers/11287684 | PubMed |
| 10931921 | Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10931921 | PubMed |
| 10694813 | Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer. | Gene Ther | 2000 | https://conductscience.org/library/papers/10694813 | PubMed |
| 10400815 | Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. | J Virol | 1999 | https://conductscience.org/library/papers/10400815 | PubMed |
| 10233987 | Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. | J Virol | 1999 | https://conductscience.org/library/papers/10233987 | PubMed |
| 9722635 | RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates. | Nucleic Acids Res | 1998 | https://conductscience.org/library/papers/9722635 | PubMed |
| 9611232 | TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer. | Nucleic Acids Res | 1998 | https://conductscience.org/library/papers/9611232 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| RBM8A | 9939 | PubTator's text mining | https://conductscience.org/library/genes/9939 | NCBI Gene |
| TAT | 6898 | PubTator's text mining | https://conductscience.org/library/genes/6898 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8367455
GET https://conductscience.org/api/papers/v1/8367455/references?page=2